GUMDROP : Phase II Study to Evaluate the Efficacy of Intensity Modulated Radiation Therapy with Hypofractionated Radiosurgical Boosts in the Treatment of Clinically Localized Prostate Cancer

Created by Nancy Dawson, last modified by Leonard Chen on Jun 14, 2012

Description:

This is a phase II study designed to prospectively evaluate the efficacy and morbidity of IMRT with CyberKnife radiosurgical boosts for clinically localized prostate cancer. Patients with clinically localized prostate cancer will be treated with three radiosurgical treatments (6.5 Gy per fraction to the PTV) followed by IMRT (45 Gy in 25 fractions). Treatment will be completed over a 6-7 week period.

Link:

http://clinicaltrials.gov/show/NCT01618851

Site:

Georgetown University Hospital

Principal Investigator:

Dr. Sean Collins